Investor Relations Outlook: Transforming Trends into Opportunities for 2024

December 14, 2023
2:00-3:00pm Eastern Time

From increased market volatility to greater regulatory complexity, IR teams faced numerous challenges in 2023. Despite these hurdles, IR professionals emerged as strategic partners, playing a pivotal role in guiding companies through uncertain times. As we reflect on 2023, join us in exploring what lies ahead for IR in 2024. Our panel of experts will highlight trends they anticipate will shape the market and industry. Through practical examples, we'll demonstrate the tangible impact of these trends on investor relations teams across diverse sectors. You’ll gain actionable insights to proactively navigate what’s ahead, ensuring your company's investor relations efforts remain competitive and responsive to investor expectations in 2024 and beyond.


  • Mark Fasken, COO, Irwin 
  • Emily Geer, SVP, Senior Director, Corporates Business Unit, FactSet
  • Meaghan Montegari, Managing Director, ICR
  • Cassie Corneau, Director, Head of Investor Relations & Strategic Finance, 10x Genomics